Recursion Pharmaceuticals, Inc. is rated a Sell due to cash burn, Q3 net loss of $162.25M and operational trends. Learn more ...
When cases of plague pop up in the US, it can feel straight up medieval. It's treatable, but how and why does it persist?
It’s happened to all of us: you find the perfect model for your needs — a bracket, a box, a cable clip, but it only comes in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback